A new drug to prevent migraine called TEV-48125 was associated with fewer headache hours for people with chronic migraine within three to seven days after the first injection, according to a study published in the June 8th, 2016, online issue of Neurology®, the medical journal of the American Academy of Neurology. Chronic migraine is defined… Continue reading New Drug to Prevent Migraine May Start Working in Days